Evidence map›Paper›PMID 31171939›Full record

ArticleGut pathogens2019

High frequency of toxigenic

Alex J Forero, Marina Muñoz, Milena Camargo, Sara C Soto-De León, Dora I Ríos-Chaparro, Claudia Birchenall, Darío Pinilla, Juan M Pardo, Diego F Josa, Manuel A Patarroyo and 1 more

Open access · goldAbstract read
In one paragraph

Article in Gut pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Microbiology spectrum · 2026
    Article
  4. Deadly Diarrhea Caused by Co-Infection ofInfection and drug resistance · 2025
    Article
  5. Article
  6. Article
  7. Occurrence ofPathogens (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Alex J Forero *1Grupo de Investigaciones Microbiológicas-UR (GIMUR), Programa de Biología, Facultad de Ciencias Naturales y Matemáticas, Universidad del Rosario, Carrera 24 # 63C - 69, Bogotá, Colombia.
Marina Muñoz *1Grupo de Investigaciones Microbiológicas-UR (GIMUR), Programa de Biología, Facultad de Ciencias Naturales y Matemáticas, Universidad del Rosario, Carrera 24 # 63C - 69, Bogotá, Colombia.
Milena Camargo4Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá, Colombia.
Sara C Soto-De León5Laboratorio de Investigación Biomédica y Biología Molecular, Facultad de Ciencias de la Salud, Universidad del Sinú, Montería, Córdoba Colombia.
Dora I Ríos-Chaparro1Grupo de Investigaciones Microbiológicas-UR (GIMUR), Programa de Biología, Facultad de Ciencias Naturales y Matemáticas, Universidad del Rosario, Carrera 24 # 63C - 69, Bogotá, Colombia.
Claudia BirchenallHospital Universitario Mayor-Méderi, Bogotá, Colombia.
Darío PinillaHospital Universitario Mayor-Méderi, Bogotá, Colombia.
Juan M PardoHospital Universitario Mayor-Méderi, Bogotá, Colombia.
Diego F JosaFundación Clínica Shaio, Bogotá, Colombia.
Manuel A Patarroyo4Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá, Colombia.
Juan D Ramírez1Grupo de Investigaciones Microbiológicas-UR (GIMUR), Programa de Biología, Facultad de Ciencias Naturales y Matemáticas, Universidad del Rosario, Carrera 24 # 63C - 69, Bogotá, Colombia.ORCID 0000-0002-1344-9312
Fundación Instituto de Inmunología de Colombia · COUniversidad del Rosario · COPontificia Universidad Javeriana · COUniversidad del Sinú · COUniversidad Nacional de Colombia · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to evaluate the frequency of toxigenic

resultsWe found that 65.5% (n = 144) of the population had

conclusionsThis study is the first molecular detection and characterization of

Indexed as

Clostridium difficileClostridium perfringensCommunity-onsetDiarrheaHealth care facility onset

Identifiers

PMID31171939
PMCPMC6545673
OpenAlexW2948888457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.